CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer
- Citation:
- J Clin Oncol vol 40 (12) 1323-1334
- Year:
- 2022
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Long-Term-Followup
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 11
- Pharmas:
- Genentech
- Grants:
- U10CA180821, U10CA180882, U24CA196171, UG1CA189858, UG1CA233180, UG1CA233253, UG1CA233290, UG1CA233327, UG1CA233339, UG1CA233373, P30CA033572, P50CA58223, U10CA180888 (SWOG)
- Corr. Author:
- Authors:
- Jonathan H. Shepherd Karla Ballman Mei-Yin C. Polley Jordan D. Campbell Cheng Fan Sara Selitsky Aranzazu Fernandez-Martinez Joel S. Parker Katherine A. Hoadley Zhiyuan Hu Yan Li Matthew G. Soloway Patricia A. Spears Baljit Singh Sara M. Tolaney George Somlo Elisa R. Port Cynthia Ma Charles Kuzma Eleftherios Mamounas Mehra Golshan Jennifer R. Bellon Deborah Collyar Olwen M. Hahn Clifford A. Hudis Eric P. Winer Ann Partridge Terry Hyslop Lisa A. Carey Charles M. Perou William M. Sikov
- Networks:
- CA043, FL086, KAISER, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-NY016, NY021, RI005, SCOR
- Study
- CALGB-40603
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- ORIGINAL REPORTS, Breast Cancer